WallStreetZenWallStreetZen

NASDAQ: SRZN
Surrozen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SRZN

Based on 1 analyst offering 12 month price targets for Surrozen Inc

Min Forecast
$32.00+133.05%
Avg Forecast
$32.00+133.05%
Max Forecast
$32.00+133.05%

Should I buy or sell SRZN stock?

Based on 1 analyst offering ratings for Surrozen Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SRZN stock forecasts and price targets.

SRZN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-12

1 of 1

Forecast return on equity

Is SRZN forecast to generate an efficient return?

Company
-994.37%
Industry
256.49%
Market
145.67%
SRZN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SRZN forecast to generate an efficient return on assets?

Company
-49.13%
Industry
109.01%
SRZN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SRZN earnings per share forecast

What is SRZN's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$3.51
Avg 2 year Forecast
-$4.31
Avg 3 year Forecast
-$4.24

SRZN revenue forecast

What is SRZN's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$3.0M-71.44%
Avg 2 year Forecast
$0.0-100%
Avg 3 year Forecast
$0.0-100%

SRZN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SRZN$13.73$32.00+133.05%Buy
VTGN$4.05N/AN/A
MGNX$1.85$3.50+89.19%Buy
CGTX$1.59$3.50+120.13%Strong Buy
TVGN$0.61$10.00+1,552.89%Strong Buy
View Top Biotech Stocks

Surrozen Stock Forecast FAQ

Is Surrozen Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SRZN) stock is to Buy SRZN stock.

Out of 1 analyst, 0 (0%) are recommending SRZN as a Strong Buy, 1 (100%) are recommending SRZN as a Buy, 0 (0%) are recommending SRZN as a Hold, 0 (0%) are recommending SRZN as a Sell, and 0 (0%) are recommending SRZN as a Strong Sell.

If you're new to stock investing, here's how to buy Surrozen stock.

What is SRZN's earnings growth forecast for 2025-2027?

(NASDAQ: SRZN) Surrozen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 26.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.98%.

Surrozen's earnings in 2025 is -$81,704,000.On average, 4 Wall Street analysts forecast SRZN's earnings for 2025 to be -$30,044,395, with the lowest SRZN earnings forecast at -$28,866,183, and the highest SRZN earnings forecast at -$30,928,053. On average, 4 Wall Street analysts forecast SRZN's earnings for 2026 to be -$36,944,125, with the lowest SRZN earnings forecast at -$40,614,048, and the highest SRZN earnings forecast at -$32,546,382.

In 2027, SRZN is forecast to generate -$36,332,756 in earnings, with the lowest earnings forecast at -$46,907,548 and the highest earnings forecast at -$24,544,647.

What is SRZN's revenue growth forecast for 2025-2027?

(NASDAQ: SRZN) Surrozen's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 108.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.33%.

Surrozen's revenue in 2025 is $10,655,000.On average, 4 Wall Street analysts forecast SRZN's revenue for 2025 to be $26,055,943, with the lowest SRZN revenue forecast at $16,500,099, and the highest SRZN revenue forecast at $35,962,853. On average, 4 Wall Street analysts forecast SRZN's revenue for 2026 to be $0, with the lowest SRZN revenue forecast at $0, and the highest SRZN revenue forecast at $0.

In 2027, SRZN is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is SRZN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: SRZN) forecast ROA is -49.13%, which is lower than the forecast US Biotechnology industry average of 109.01%.

What is SRZN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SRZN price target, the average SRZN price target is $32.00, with the highest SRZN stock price forecast at $32.00 and the lowest SRZN stock price forecast at $32.00.

The Wall Street analyst predicted that Surrozen's share price could reach $32.00 by May 12, 2026. The average Surrozen stock price prediction forecasts a potential upside of 133.05% from the current SRZN share price of $13.73.

What is SRZN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SRZN) Surrozen's current Earnings Per Share (EPS) is -$24.96. On average, analysts forecast that SRZN's EPS will be -$3.51 for 2025, with the lowest EPS forecast at -$3.37, and the highest EPS forecast at -$3.61. On average, analysts forecast that SRZN's EPS will be -$4.31 for 2026, with the lowest EPS forecast at -$4.74, and the highest EPS forecast at -$3.80. In 2027, SRZN's EPS is forecast to hit -$4.24 (min: -$5.48, max: -$2.87).

What is SRZN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: SRZN) forecast ROE is -994.37%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.